Fusogenic liposomes: the innovative delivery of compounds into human platelets to reduce animal use in platelet research

血小板缺乏细胞核，这意味着用于研究有核细胞的传统方法无法应用。因此，血小板领域在很大程度上依赖于转基因小鼠模型来研究血小板功能。融合性脂质体已被用于促进水溶性货物直接进入细胞的输送。本项目首次研究了融合性脂质体是否可以直接与血小板融合，以及它们是否可以作为一种将货物直接释放到血小板细胞质中的递送方法。目的开发卷积神经网络（CNN）在整个项目中自动化和标准化血小板扩散分析。目的：确定融合性脂质体是否可以与血小板联合使用而不影响血小板的正常功能。确定包裹在融合性脂质体中的货物是否可以在融合后直接运送到血小板的细胞质中。方法使用120张差示干涉对比显微镜图像对CNN进行训练，并根据独立测试集和5个手动注释器对模型性能进行评估。通过测量p -选择素暴露、磷脂酰丝氨酸易位、血小板扩散和血小板聚集来评估由于融合性脂质体与血小板膜融合对正常血小板行为的影响。结果：sa CNN消除了对人和小鼠血小板耗时且有偏差的人工分析，提供了一种工具，可用于在更广泛的血小板领域标准化血小板扩散分析。用促聚变脂质体有效地标记血小板，而不会对正常血小板功能造成显著影响。这为体外和体内应用提供了一种荧光标记血小板的替代方法。融合性脂质体将荧光标记的Lifeact肽和整个抗体货物运送到血小板细胞质中。这使得细胞内过程能够在活血小板中进行研究，并有可能在人血小板中实现抗体介导的蛋白敲低，从而减少使用动物模型血小板的需要。

Background Platelets lack a nucleus meaning that conventional methods, used to investigate nucleated cells, cannot be applied. As a result, the platelet field has become heavily reliant on genetically modified mouse models to investigate platelet function. Fusogenic liposomes have been used to facilitate the delivery of water-soluble cargo directly into cells. This project investigates, for the first time, if fusogenic liposomes can fuse directly with platelets and if they can be used as a delivery method to release cargo directly into the cytoplasm of platelets. Aims To develop a convolutional neural network (CNN) to automate and standardise platelet spreading analyses throughout this project. To determine if fusogenic liposomes can be used in combination with platelets without impacting on normal platelet function. To identify if cargo, encapsulated in fusogenic liposomes, can be delivered directly to the cytoplasm of platelets following fusion. MethodsA CNN was trained using 120 Differential Interference Contrast microscopy images where model performance was evaluated against an independent test set and five manual annotators. Any impact on normal platelet behaviour, due to fusion by fusogenic liposomes with the platelet membrane, was assessed by measuring P-selectin exposure, phosphatidylserine translocation, platelet spreading, and platelet aggregation. ResultsA CNN abrogates time consuming and biased manual analyses for both human and mouse platelets, delivering a tool that can be used to standardise platelet spreading assays in the wider platelet field. Platelets were efficiently labelled with fusogenic liposomes without causing significant impact to normal platelet function. This offers an alternative method to fluorescently label platelets for in vitro and in vivo applications. Fusogenic liposomes delivered fluorescently labelled Lifeact peptides and whole antibody cargo into the platelet cytoplasm. This enables intracellular processes to be studied in live platelets, with the potential to allow antibody-mediated protein knockdown in human platelets, reducing the need to use platelets from animal models.